MAP3K7 and hepatocellular carcinoma: Similarly, hepatocyte-specific TAK1 ablation drives RIPK1 kinase-dependent inflammation to promote liver fibrosis and HCC (Su et al., 2023; Tan et al., 2020; Xia et al., 2021).